FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eric Haura

Research Profile

Disorders

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Mark G Alexandrow; Soner Altiok; Jhanelle Gray; Eric Haura; Lanxi J Song; Nagi B Kumar
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer.
Yun Bai; Marilyn Bui; Arthur Edwards; Steven Eschrich; Bin Fang; John Koomen; Jiannong Li; Guolin Zhang; Soner Altiok; Eric Haura
Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.
George R Simon; Scott Antonia; Mubeena Begum; Alberto Chiappori; Eric Haura; Jongphil Kim; Michael J Schell; Gerold Bepler
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eric Haura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mark G Alexandrow; Soner Altiok; Jhanelle Gray; Eric Haura; Lanxi J Song; Nagi B Kumar
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2012;21(5):407-12.
2012: Yun Bai; Marilyn Bui; Arthur Edwards; Steven Eschrich; Bin Fang; John Koomen; Jiannong Li; Guolin Zhang; Soner Altiok; Eric Haura
Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.
Cancer research 2012;72(10):2501-11.
2012: George R Simon; Scott Antonia; Mubeena Begum; Alberto Chiappori; Eric Haura; Jongphil Kim; Michael J Schell; Gerold Bepler
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis.
Cancer 2012;118(9):2525-31.
2012: Sandeep Singh; Jose Trevino; Soner Altiok; Namrata Bora-Singhal; Domenico Coppola; Eric Haura; Srikumar P Chellappan
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
Molecular cancer 2012;11():73.
2011: George R Simon; Christopher A Slapak; Mika A Sovak; Ann L Cleverly; Dinesh P de Alwis; Eric Haura; Robert L Ilaria; Mary A Miller; Amanda K Sykes; Margaret M Wagner; Charles C Williams; David R Spriggs
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors.
Cancer chemotherapy and pharmacology 2011;68(5):1233-41.
2011: Takeshi Yoshida; Eric Haura
The potential benefits of BIM in the further pursuit of biomarker discovery in cancer therapeutics.
Cancer discovery 2011;1(4):289-90.
2011: Smitha Pillai; Bhupendra Rawal; Wasia Rizwani; Michael J Schell; Domenico Coppola; Eric Haura; Xueli Li; Sajitha Nair; Gerold Bepler; Srikumar Chellappan
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.
Molecular and cellular biology 2011;31(14):3052-67.
2011: Gerold Bepler; Thomas J Dilling; Henry N Wagner; Todd Hazelton; Charles Williams; Dung-Tsa Chen; Harvey Greenberg; Frank Walsh; George Simon; Tawee Tanvetyanon; Alberto Chiappori; Eric Haura; Craig Stevens
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(3):553-8.
2011: Lanxi Song; Bhupendra Rawal; Jeffrey A Nemeth; Eric Haura
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Molecular cancer therapeutics 2011;10(3):481-94.
2011: Piyali Dasgupta; Wasia Rizwani; Smitha Pillai; Rebecca Davis; Sarmistha Banerjee; Kevin Hug; Mark Lloyd; Domenico Coppola; Eric Haura; Srikumar Chellappan
ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors.
Journal of the National Cancer Institute 2011;103(4):317-33.
2011: Guolin Zhang; Bin Fang; Richard Z Liu; Huiyi Lin; Fumi Kinose; Yun Bai; Umut Oguz; Elizabeth R Remily-Wood; Jiannong Li; Soner Altiok; Steven Eschrich; John Koomen; Eric Haura
Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.
Journal of proteome research 2011;10(1):305-19.
2011: Eric Haura; André Müller; Florian P Breitwieser; Jiannong Li; Florian Grebien; Jacques Colinge; Keiryn Bennett
Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer.
Journal of proteome research 2011;10(1):182-90.
2010: Eric Haura; Eric Sommers; Lanxi Song; Alberto Chiappori; Aaron Becker
A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(11):1806-14.
2010: Takeshi Yoshida; Guolin Zhang; Eric Haura
Targeting epidermal growth factor receptor: central signaling kinase in lung cancer.
Biochemical pharmacology 2010;80(5):613-23.
2010: Bin Fang; Eric Haura; Keiran S Smalley; Steven A Eschrich; John M Koomen
Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling.
Biochemical pharmacology 2010;80(5):739-47.
2010: Sacha I Rothschild; Oliver Gautschi; Eric Haura; Faye M Johnson
Src inhibitors in lung cancer: current status and future directions.
Clinical lung cancer 2010;11(4):238-42.
2010: Tawee Tanvetyanon; Lary Robinson; K Eric Sommers; Eric Haura; Jongphil Kim; Soner Altiok; Gerold Bepler
Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(7):1018-24.
2010: Eric Haura; D Ross Camidge; Karen Reckamp; Alberto Chiappori; Faye Johnson; Roy Herbst; Kwok Wong; David Carbone
Molecular origins of lung cancer: prospects for personalized prevention and therapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6 Suppl 3):S207-13.
2010: Eric Haura; Alejandro D Ricart; Timothy G Larson; Philip J Stella; Lyudmila Bazhenova; Vincent A Miller; Roger B Cohen; Peter D Eisenberg; Paulina Selaru; Keith D Wilner; Shirish M Gadgeel
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2450-7.
2010: Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric Haura
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
Nature chemical biology 2010;6(4):291-9.
2010: Eric Haura; Tawee Tanvetyanon; Alberto Chiappori; Charles Williams; George Simon; Scott J Antonia; Jhanelle Gray; Sharon Litschauer; Leticia Tetteh; Anthony Neuger; Lanxi Song; Bhupendra Rawal; Michael J Schell; Gerold Bepler
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(8):1387-94.
2010: Lori C Kim; Uwe Rix; Eric Haura
Dasatinib in solid tumors.
Expert opinion on investigational drugs 2010;19(3):415-25.
2010: William Brazelle; Jenny M Kreahling; Jennifer Gemmer; Yihong Ma; W Douglas Cress; Eric Haura; Soner Altiok
Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.
PloS one 2010;5(12):e14335.
2010: Kazuya Machida; Steven Eschrich; Jiannong Li; Yun Bai; John Koomen; Bruce J Mayer; Eric Haura
Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling.
PloS one 2010;5(10):e13470.
2009: Lori C Kim; Lanxi Song; Eric Haura
Src kinases as therapeutic targets for cancer.
Nature reviews. Clinical oncology 2009;6(10):587-95.
2009: Jingchun Gao; Zhong Zheng; Bhupendra Rawal; Michael J Schell; Gerold Bepler; Eric Haura
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Cancer biology & therapy 2009;8(17):1671-9.
2009: Jingchun Gao; Matthew J McConnell; Bin Yu; Jiannong Li; Justin M Balko; Esther P Black; Joseph O Johnson; Mark C Lloyd; Soner Altiok; Eric Haura
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.
International journal of oncology 2009;35(2):337-45.
2009: Rebecca Davis; Wasia Rizwani; Sarmistha Banerjee; Michelle Kovacs; Eric Haura; Domenico Coppola; Srikumar Chellappan
Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.
PloS one 2009;4(10):e7524.
2009: Piyali Dasgupta; Wasia Rizwani; Smitha Pillai; Rebecca Kinkade; Michelle Kovacs; Shipra Rastogi; Sarmistha Banerjee; Melanie A Carless; Esther Kim; Domenico Coppola; Eric Haura; Srikumar Chellappan
Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines.
International journal of cancer. Journal international du cancer 2009;124(1):36-45.
2008: Dihui Lu; Richard Z Liu; Victoria Izumi; David Fenstermacher; Eric Haura; John Koomen; Steven A Eschrich
IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry.
Bioinformatics (Oxford, England) 2008;24(23):2801-2.
2008: Gerold Bepler; K Eric Sommers; Alan Cantor; Xueli Li; Anupama Sharma; Charles Williams; Alberto Chiappori; Eric Haura; Scott Antonia; Tawee Tanvetyanon; George Simon; Coleman Obasaju; Lary A Robinson
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(10):1112-8.
2008: John M Koomen; Eric Haura; Gerold Bepler; Rebecca Sutphen; Elizabeth R Remily-Wood; Kaaron Benson; Mohamad Hussein; Lori A Hazlehurst; Timothy J Yeatman; Lynne T Hildreth; Thomas A Sellers; Paul B Jacobsen; David A Fenstermacher; William S Dalton
Proteomic contributions to personalized cancer care.
Molecular & cellular proteomics : MCP 2008;7(10):1780-94.
2008: George R Simon; Martine Extermann; Alberto Chiappori; Charles C Williams; Mubeena Begum; Rachna Kapoor; Eric Haura; Roohi Ismail-Khan; Michael J Schell; Scott J Antonia; Gerold Bepler
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
Cancer 2008;112(9):2021-9.
2008: Alberto Chiappori; Eric Haura; Francisco A Rodriguez; David Boulware; Rachna Kapoor; Anthony M Neuger; Richard M Lush; Barbara Padilla; Michelle Burton; Charles Williams; George Simon; Scott J Antonia; Daniel M Sullivan; Gerold Bepler
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1464-9.
2008: Jiannong Li; Jean Viallet; Eric Haura
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
Cancer chemotherapy and pharmacology 2008;61(3):525-34.
2007: Arthur Edwards; Jiannong Li; Peter Atadja; Kapil N Bhalla; Eric Haura
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells.
Molecular cancer therapeutics 2007;6(9):2515-24.
2007: George Simon; Anupama Sharma; Xueli Li; Todd Hazelton; Frank Walsh; Charles Williams; Alberto Chiappori; Eric Haura; Tawee Tanvetyanon; Scott J Antonia; Alan Cantor; Gerold Bepler
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2741-6.
2007: GILBERTO LOPES; Alberto Chiappori; George Simon; Eric Haura; Dan Sullivan; Scott J Antonia; Michael Langevin; Richard M Lush; Caio Rocha Lima
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
Cancer 2007;109(7):1413-9.
2007: Jiannong Li; Bin Yu; Lanxi Song; Steve Eschrich; Eric Haura
Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cells.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007;27(3):209-20.
2007: Zhong Zheng; Tingan Chen; Xueli Li; Eric Haura; Anupama Sharma; Gerold Bepler
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
The New England journal of medicine 2007;356(8):800-8.
2006: Piyali Dasgupta; Shipra Rastogi; Smitha Pillai; Dalia Ordonez-Ercan; Mark Morris; Eric Haura; Srikumar Chellappan
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways.
The Journal of clinical investigation 2006;116(8):2208-2217.
2006: Eric Haura
SRC and STAT pathways.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):403-5.
2006: Lanxi Song; Mark Morris; Tapan Bagui; Francis Y Lee; Richard Jove; Eric Haura
Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
Cancer research 2006;66(11):5542-8.
2006: Piyali Dasgupta; Rebecca Kinkade; Bharat Joshi; Christina Decook; Eric Haura; Srikumar Chellappan
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(16):6332-7.
2006: Justin M Balko; Anil Potti; Christopher Saunders; Arnold Stromberg; Eric Haura; Esther P Black
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
BMC genomics 2006;7():289.
2006: Eric Haura
Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
Medical hypotheses 2006;67(4):951-6.
2006: Eric Haura; Sandy Livingston; Domenico Coppola
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.
Clinical lung cancer 2006;7(4):273-5.
2005: Eric Haura; Zhong Zheng; Lanxi Song; Alan Cantor; Gerold Bepler
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8288-94.
2005: Scott N Freeman; Gerold Bepler; Eric Haura; Rebecca Sutphen; W.Douglas Cress
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Journal of the National Cancer Institute 2005;97(14):1088-9; author reply 1093-5.
2005: Zhong Zheng; Gerold Bepler; Alan Cantor; Eric Haura
Small tumor size and limited smoking history predicts activated epidermal growth factor receptor in early-stage non-small cell lung cancer.
Chest 2005;128(1):308-16.
2005: Eric Haura; James Turkson; Richard Jove
Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
Nature clinical practice. Oncology 2005;2(6):315-24.
2005: Daniel J Dauer; Bernadette Ferraro; Lanxi Song; Bin Yu; Linda B Mora; Ralf Buettner; Steven A Enkemann; Richard Jove; Eric Haura
Stat3 regulates genes common to both wound healing and cancer.
Oncogene 2005;24(21):3397-408.
2005: Bernadette Ferraro; Gerold Bepler; Swati Sharma; Alan Cantor; Eric Haura
EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1921-6.
2005: Lanxi Song; Domenico Coppola; Sandy Livingston; Doug Cress; Eric Haura
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
Cancer biology & therapy 2005;4(3):267-76.
2005: Gerold Bepler; Zhong Zheng; Ashish Gautam; Swati Sharma; Alan Cantor; Anupama Sharma; W.Douglas Cress; Young-Chul Kim; Rafael Rosell; Colleen McBride; Lary Robinson; Eric Sommers; Eric Haura
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance.
Lung cancer (Amsterdam, Netherlands) 2005;47(2):183-92.
2005: Alberto Chiappori; George Simon; Charles Williams; Eric Haura; Caio Rocha Lima; Henry Wagner; Gerold Bepler; Scott J Antonia
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Oncology 2005;68(4-6):382-90.
2004: Brandon A Howard; Zhong Zheng; Michael J Campa; Zhuo Wang; Anupama Sharma; Eric Haura; James E Herndon; Michael C Fitzgerald; Gerold Bepler; Edward F Patz
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46(3):313-23.
2004: Eric Haura; W.Douglas Cress; Srikumar Chellappan; Zhong Zheng; Gerold Bepler
Antiapoptotic signaling pathways in non-small-cell lung cancer: biology and therapeutic strategies.
Clinical lung cancer 2004;6(2):113-22.
2004: Gina D'Amato; Caio Rocha Lima; J Joseph Mahany; Carlos Muro-Cacho; Eric Haura
Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):381-90.
2004: Gerold Bepler; Swati Sharma; Alan Cantor; Ashish Gautam; Eric Haura; George Simon; Anupama Sharma; Eric Sommers; Lary Robinson
RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1878-85.
2004: James Turkson; Joon S Kim; Shumin Zhang; Jing Yuan; Mei Huang; Matthew Glenn; Eric Haura; Said Sebti; Andrew D Hamilton; Richard Jove
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.
Molecular cancer therapeutics 2004;3(3):261-9.
2004: Paul Hauser; Le Ma; Deepak Agrawal; Eric Haura; W.Douglas Cress; Warren Pledger
Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
Molecular cancer research : MCR 2004;2(2):96-104.
2003: Eric Haura; Eduardo M Sotomayor; Scott J Antonia
Gene therapy for lung cancer.
Molecular biotechnology 2003;25(2):139-48.
2003: Tapan K Bagui; Subhra Mohapatra; Eric Haura; Warren Pledger
P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
Molecular and cellular biology 2003;23(20):7285-90.
2003: George R Simon; John Ruckdeschel; Charles Williams; Alan Cantor; Alberto Chiappori; Caio Rocha Lima; Scott J Antonia; Eric Haura; Henry Wagner; Lary Robinson; Eric Sommers; Michael Alberts; Gerold Bepler
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.
Cancer control : journal of the Moffitt Cancer Center 2003;10(5):388-95.
2003: Lanxi Song; James Turkson; James Karras; Richard Jove; Eric Haura
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Oncogene 2003;22(27):4150-65.
2003: Yihong Ma; W.Douglas Cress; Eric Haura
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Molecular cancer therapeutics 2003;2(1):73-81.
2003: Eric Haura; Eduardo M Sotomayor; Scott J Antonia
Gene therapy for lung cancer. An introduction.
Methods in molecular medicine 2003;75():529-43.
2002: Carme Sarries; Eric Haura; Barbara Roig; Miquel Taron; Albert Abad; Giorgio V Scagliotti; Rafael Rosell
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.
Pharmacogenomics 2002;3(6):763-80.
2002: Eric Haura
Management of advanced non-small cell lung cancer: current trends.
Current opinion in pulmonary medicine 2002;8(4):251-6.
2002: Eric Haura; Mark A Winden; Alan D Proia; James E Trotter
Fulminant hepatic failure due to disseminated adenovirus infection in a patient with chronic lymphocytic leukemia.
Cancer control : journal of the Moffitt Cancer Center 2002;9(3):248-53.
2002: Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline F Bromberg; Drew M Pardoll; Richard Jove; Hua Yu
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
Oncogene 2002;21(13):2000-8.
2002: Rhonda Croxton; Yihong Ma; Lanxi Song; Eric Haura; W.Douglas Cress
Direct repression of the Mcl-1 promoter by E2F1.
Oncogene 2002;21(9):1359-69.
2001: James Turkson; D Ryan; Joon S Kim; Y Zhang; Z Chen; Eric Haura; A Laudano; Said Sebti; Andrew D Hamilton; Richard Jove
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.
The Journal of biological chemistry 2001;276(48):45443-55.
2001: Eric Haura
Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.
Cancer control : journal of the Moffitt Cancer Center 2001;8(4):326-36.
2000: Rosalie C Pelz; F Nuckolls; Eric Haura; Y Taya; Katsuyuki Tamai; Joseph R Nevins
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.
Genes & development 2000;14(19):2501-14.